News

A preliminary analysis of an ongoing study shows that most patients diagnosed with lung cancer before age 40 had an increased chance for a targeted genomic alteration, knowledge of which could lead to more effective, targeted treatment.

Palliative care should address the unique symptom profile of gynecologic cancer and be tailored to individual socioeconomic environments.

Every year, thousands of children are diagnosed with cancer in the United States. Sherrie and Michael Wells started the Hugs for Brady Foundation to help end pediatric cancer for good.

Study suggests that "vaping" is likely to lead to tobacco smoking among adolescents.

Sharsheret is a national not-for-profit organization supporting young Jewish women and their families facing breast cancer and ovarian cancer.

Young black women have a higher prevalence of BRCA mutations compared with that previously reported among non-Hispanic white women, placing these women at a higher risk for breast and ovarian cancer.

Despite its known effectiveness in reducing breast cancer recurrence, many young women are bypassing taking tamoxifen because of fertility concerns.

Patients and caregivers join ALCF leadership to enhance patient programs and services

For many patients, finding the right clinical trial is challenging and complex. Advocacy organizations like The Colon Club can help.

In November 2009, just less than 2 months after losing their only child, Mattie to osteosarcoma at age 7, Peter and Victoria Brown created the Mattie Miracle Cancer Foundation.

Oncology practitioners now have a new drug in their armamentarium to help prevent chemotherapy-induced nausea and vomiting (CINV) following the FDA's approval today of the oral agent rolapitant (Varubi).

Clinicians suggest that telemedicine may be helpful.

Like many advocates of a cause, Amy Byer Shainman's passion came from a place of frustration.

Marguerite Regan, PhD, was diagnosed with Waldenstrom's macroglobulinemia in 1995 and shares practical wisdom from her experiences, including reminding patients that WM isa treatable illness, not an end game.

Ten years after founding The Julie Fund for Women's Cancers, President Peter McAvinn's resolve is stronger than ever.

Listening to music before undergoing ambulatory surgery for the diagnosis or treatment of breast cancer lessens patients' anxiety levels.

Teenagers who use electronic cigarettes by the time that they start high school are more likely to start smoking conventional cigarettes and develop a nicotine addiction within the next year.

For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.

For patients dealing with cancer, a daily dose of inspiration may make a big difference in their outlook on life.

Patients who have human papillomavirus 16 DNA in their saliva following treatment of their oropharyngeal cancer are more likely to have their cancer recur, and a simple mouth rinse can be used to detect it.

Meta-analysis of 148 studies confirms benefit of spirituality and religion.

Rates of endometrial cancer continue to increase among all racial and ethnic groups, but they're rising faster among non-Hispanic black women who also have poorer outcomes when compared with their white, non-Hispanic counterparts.

Patients with Hodgkin lymphoma at risk of relapse or progression have a new treatment option following the FDA's expansion of the approved use of brentuximab vedotin (Adcetris).

Researchers at Oregon Health & Science University found that breast cancer survivors who experience pain during sexual intercourse may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

Lung cancer at any age is a catastrophic illness, but it is particularly devastating when it affects young adults in the prime of their lives.

A donation from Bristol-Myers Squibb Company to The Leukemia & Lymphoma Society (LLS) will provide financial assistance for chronic myeloid leukemia (CML) patients who need help paying for Polymerase Chain Reaction (PCR) testing.

Study finds long-term survival is not unusual.

Results from the phase III TELESTAR trial showed that oral telotristat etiprate proved much better than placebo in reducing carcinoid syndrome–related diarrhea.

Less than 50% of patients with ovarian cancer who could benefit from intraperitoneal chemotherapy actually receive it, despite research suggesting that this technique could improve survival for these patients.

Guidelines for metastatic breast cancer developed.